By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

TapImmune Inc. 

2815 Eastlake Avenue East
Suite 300
Seattle  Washington  98102  U.S.A.
Phone: 866-359-7541 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Oncology
Vaccines





Company News
TapImmune (TPIV) Doses First Patient In Its Phase 2 Triple Negative Breast Cancer Trial For Cancer Vaccine TPIV 200 6/21/2016 7:01:34 AM
TapImmune (TPIV) Announces Finalization Of License Agreement With Mayo Clinic To Commercialize A HER2neu Vaccine 6/7/2016 10:26:01 AM
TapImmune (TPIV) To Present At The LD Micro Invitational In Los Angeles On June 7, 2016 6/6/2016 4:07:05 PM
TapImmune (TPIV) To Present At The 3rd Annual Growth Capital Expo In Las Vegas On May 4, 2016 4/28/2016 9:59:03 AM
TapImmune (TPIV) Announces Phase 2 Ovarian Cancer Trial Study With AstraZeneca PLC (AZN)/MedImmune (AZN) And Sloan Kettering Cancer Institute 4/21/2016 7:47:16 AM
TapImmune (TPIV) Completes GMP Manufacturing And Release Of TPIV 200 Vaccine 4/7/2016 10:32:19 AM
TapImmune (TPIV) To Present At 28th Annual ROTH Conference On March 16, 2016 3/14/2016 12:01:08 PM
TapImmune (TPIV) Receives Notice Of Allowance On U.S. Patent Claims For PolyStart - Next-Generation T-Cell Vaccine 2/18/2016 7:37:22 AM
TapImmune (TPIV) Sponsors 26.2 With DONNA Marathon For Breast Cancer Research And Care 2/10/2016 10:09:29 AM
TapImmune (TPIV) To Present At Source Capital's 2016 Disruptive Growth & Healthcare Conference On February 10, 2016 2/8/2016 9:13:15 AM
12345678910...
//-->